COGT
Price
$10.39
Change
+$0.62 (+6.34%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
1.18B
34 days until earnings call
IMNM
Price
$8.88
Change
+$0.33 (+3.86%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
773.54M
35 days until earnings call
Interact to see
Advertisement

COGT vs IMNM

Header iconCOGT vs IMNM Comparison
Open Charts COGT vs IMNMBanner chart's image
Cogent Biosciences
Price$10.39
Change+$0.62 (+6.34%)
Volume$104.35K
Capitalization1.18B
Immunome
Price$8.88
Change+$0.33 (+3.86%)
Volume$74.98K
Capitalization773.54M
COGT vs IMNM Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. IMNM commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and IMNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (COGT: $9.78 vs. IMNM: $8.55)
Brand notoriety: COGT and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 243% vs. IMNM: 81%
Market capitalization -- COGT: $1.18B vs. IMNM: $773.54M
COGT [@Biotechnology] is valued at $1.18B. IMNM’s [@Biotechnology] market capitalization is $773.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, both COGT and IMNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 3 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 4 bearish.
  • IMNM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, COGT is a better buy in the short-term than IMNM.

Price Growth

COGT (@Biotechnology) experienced а +35.46% price change this week, while IMNM (@Biotechnology) price change was +1.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.91%. For the same industry, the average monthly price growth was +17.27%, and the average quarterly price growth was +18.94%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

IMNM is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+12.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.18B) has a higher market cap than IMNM($774M). COGT YTD gains are higher at: 25.385 vs. IMNM (-19.492). IMNM has higher annual earnings (EBITDA): -175.18M vs. COGT (-284.04M). IMNM has more cash in the bank: 317M vs. COGT (246M). IMNM has less debt than COGT: IMNM (4.77M) vs COGT (17.1M). IMNM has higher revenues than COGT: IMNM (10.9M) vs COGT (0).
COGTIMNMCOGT / IMNM
Capitalization1.18B774M153%
EBITDA-284.04M-175.18M162%
Gain YTD25.385-19.492-130%
P/E RatioN/AN/A-
Revenue010.9M-
Total Cash246M317M78%
Total Debt17.1M4.77M358%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
11

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTIMNM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLCGX17.28N/A
N/A
VALIC Company I Large Capital Growth
MKVBX15.89N/A
N/A
MFS International Large Cap Value A
CEIIX13.47N/A
N/A
Manning & Napier Callodine Equity Inc I
NWABX32.53-0.01
-0.03%
Nationwide R6
CCDVX18.99-0.06
-0.31%
Calamos Dividend Growth C

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+4.60%
SPHDF - COGT
63%
Loosely correlated
N/A
IDYA - COGT
55%
Loosely correlated
+1.37%
ATXS - COGT
52%
Loosely correlated
+3.39%
CRNX - COGT
51%
Loosely correlated
+1.07%
IMNM - COGT
50%
Loosely correlated
-1.61%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-1.61%
IDYA - IMNM
60%
Loosely correlated
+1.37%
RXRX - IMNM
56%
Loosely correlated
+8.72%
BEAM - IMNM
54%
Loosely correlated
+5.84%
ARWR - IMNM
54%
Loosely correlated
+4.16%
SYRE - IMNM
53%
Loosely correlated
+2.03%
More